trapidil has been researched along with Atherogenesis in 1 studies
Trapidil: A coronary vasodilator agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Based on this concept, we have performed several large-scale clinical trials to provide EBM, including the Japanese Antiplatelets Myocardial Infarction Study [JAMIS; clinical improvement in acute myocardial infarction (AMI) patients with antiplatelet therapy], the Japanese beta-Blockers and Calcium Antagonists Myocardial Infarction (JBCMI; comparison of the effects of beta-blockers and calcium antagonists on cardiovascular events in post-AMI patients), a multicenter study for aggressive lipid-lowering strategy by HMG-CoA reductase inhibitors in patients with AMI (MUSASHI; effects of statin therapy on cardiovascular events in patients with AMI), and the Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD trial; efficacy of low-dose aspirin therapy for primary prevention of atherosclerotic events in type 2 diabetic patients)." | 4.85 | Clinical evidence for Japanese population based on prospective studies--linking clinical trials and clinical practice. ( Kojima, S; Ogawa, H, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogawa, H | 1 |
| Kojima, S | 1 |
1 review available for trapidil and Atherogenesis
| Article | Year |
|---|---|
Clinical evidence for Japanese population based on prospective studies--linking clinical trials and clinical practice.
Topics: Adrenergic beta-Antagonists; Aged; Asian People; Aspirin; Atherosclerosis; Calcium Channel Blockers; | 2009 |